Moleculin BiotechMBRX
13F holders, Q1 2025 (March 31)23holders +2
6new positions
4sold out
$0.97avg. 13F price*
At the end of Q1 2025, 23 institutions reported holding Moleculin Biotech Inc. (MBRX) in their 13F filings, up 2 from Q4 2024. 6 opened new positions and 4 sold out. The largest holders were Armistice Capital, LLC ($1.2M), Cetera Investment Advisers ($68K) and LPL Financial LLC ($45K).
- Company
- Moleculin Biotech Inc.
- CUSIP
- 60855D309
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $95K |
| Exits | 4 | $40K |
All 13F filers, Q4 2024 → Q1 2025: 1,039,675 shares bought and 25,998 shares sold, net +1,013,677 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Armistice Capital, LLC | 0.03% | Add +293.6% | 1,250,000 | $1.2M |
| Cetera Investment Advisers | 0.00% | New | 70,000 | $68K |
| LPL Financial LLC | 0.00% | Add +11.8% | 46,080 | $45K |
| Vanguard Group Inc. | 0.00% | No change | 30,935 | $30K |
| Geode Capital Management, LLC | 0.00% | Add +18.3% | 26,057 | $25K |
| BlackRock, Inc. | 0.00% | No change | 12,380 | $12K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | New | 12,781 | $12K |
| XTX Topco Ltd | 0.00% | New | 11,575 | $11K |
| Truist Financial Corp. | 0.00% | No change | 10,500 | $10K |
| Citigroup Inc. | 0.00% | New | 2,788 | $3K |
| NFSG Corp | 0.00% | No change | 1,367 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -66.5% | 1,348 | $1K |
| Morgan Stanley | 0.00% | Add +117.4% | 926 | $901 |
| SBI Securities Co., Ltd. | 0.00% | Add +84.2% | 746 | $726 |
| Barclays PLC | 0.00% | New | 344 | $335 |
| Bogart Wealth, LLC | 0.00% | No change | 300 | $292 |
| Sandy Spring Bank | 0.00% | No change | 89 | $87 |
| Osaic Holdings, Inc. | 0.00% | Reduce -12.2% | 43 | $41 |
| FMR LLC | 0.00% | New | 34 | $33 |
| CVA Family Office, LLC | 0.00% | No change | 34 | $33 |
| Bank of America Corp. | 0.00% | Reduce -69.2% | 32 | $31 |
| North Star Investment Management Corp. | 0.00% | No change | 17 | $17 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is MBRX's weight in each manager's 13F, not the share of Moleculin Biotech Inc. the manager owns.